| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Schulman Amy W is a Director at CYCN, with reported holdings spanning 5 companies. Recent filings cover 3 purchases and 5 sales. Those positions are worth an estimated $9.7M at current prices.
Our model assigns Schulman Amy W a below-average insider score of 22/100, based on 3 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -64.9%.
Schulman Amy W's largest disclosed position is in CYCN as Director, worth about $9.7M. Net of sales, the recent Form 4 record there shows accumulation of 626,117 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | ELV Elevance Health, Inc. | Director | Sell | 26 | $287.50 | $7,475.00 | -10.7% | +40.5% | - | |
| Mar 13, 2025 | GUTS Fractyl Health, Inc. | Director | Buy | 8,550 | $1.17 | $9,964.17 | New | +88.4% | -61.3% | |
| Jun 25, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 8,500 | $240.00 | $2,040,000.00 | -50.2% | +13.2% | +34.1% | |
| May 29, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 21,700 | $148.60 | $3,224,546.17 | -72.0% | +90.7% | +99.3% | |
| Apr 8, 2019 | CYCN Cyclerion Therapeutics, Inc. | Director | Buy | 626,117 | $16.00 | $10,017,872.00 | -103.6% | - | - |